Glass House Brands, the largest cannabis cultivation facility in America, is set to begin trading on the New York Stock Exchange (NYSE) on June 30, 2026. The company, located in Camarillo, California, anticipates cultivating 1 million pounds of cannabis and generating up to $245 million in sales by the end of the year. This follows a revenue of $182 million in 2025, down from $201 million in 2024, partly due to a federal immigration raid that affected two of its three facilities last summer.
Company Overview
Glass House operates a 165-acre greenhouse complex, which is the largest in the country at 5.5 million square feet. The company has established itself as California's premier industrial wholesale cannabis supplier since its founding eleven years ago. Co-founder Graham Farrar noted,
In high school, I did say I wanted to be the biggest drug dealer in the world, and I accomplished that in some measure.
Despite not leading in overall cannabis sales—Connecticut-based Curaleaf reported $1.3 billion in revenue in 2025—Glass House's cultivation capacity positions it uniquely in the market.
Market Positioning
The upcoming listing on the NYSE will make Glass House the second American marijuana company to trade on the exchange, following Trulieve's recent uplisting. The company aims to leverage its scale and operational efficiency to capture a larger share of the growing cannabis market. As cannabis legalization expands in various states, Glass House's strategic positioning could enhance its competitive advantage.
Related coverage: Iran Strikes Kuwait, Bahrain After US Attacks on Targets.
Sources: forbes.com, forbes.com.
The entry of Glass House Brands into the NYSE is likely to attract investor interest in the cannabis sector, potentially boosting the stock prices of publicly traded cannabis companies. Investors may focus on the implications of increased cultivation capacity and projected sales growth on market dynamics.
Watch for the company's performance metrics following its NYSE debut, which will provide insights into investor sentiment and market trends in the cannabis industry.